• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异恶唑衍生物作为强效抗炎剂的合成、表征、分子对接及药理评价

Synthesis, characterization, molecular docking and pharmacological evaluation of isoxazole derivatives as potent anti-inflammatory agents.

作者信息

Yt Kamal, Gautam Girendra Kumar, Mishra Arun Kumar, Parveen Baby Rabiya, Kumar Arvind, Singh Mhaveer, Singh Harpreet

机构信息

Drug Design Laboratory, School of Pharmaceutical Sciences, IFTM University, 244102, Moradabad, India.

Department of Pharmaceutical Chemistry, Shri Ram College of Pharmacy, Muzaffarnagar, 251001, India.

出版信息

Heliyon. 2024 Nov 15;10(22):e40300. doi: 10.1016/j.heliyon.2024.e40300. eCollection 2024 Nov 30.

DOI:10.1016/j.heliyon.2024.e40300
PMID:39641075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11617876/
Abstract

BACKGROUND

The present study is aimed to investigate the anti-inflammatory activities of thirteen substituted-isoxazole derivatives (5a-5m). Isoxazole is a key pharmacophore in medicinal chemistry, known for its broad range of pharmacological activities.This study explores the synthesis and anti-inflammatory potential of thirteen substituted-isoxazole derivatives (5a-5m), with and being novel compounds.

OBJECTIVES

The primary objectives were to synthesize some novel substituted isoxazole derivatives, evaluate their interaction with cyclooxygenase (COX-1/2) enzymes through computational methods, and assess their anti-inflammatory effectiveness in laboratory animals.

METHODS

Substituted chalcones (0.01 mol) (2a-2m), sodium ethoxide (0.01 mol), and hydroxylamine hydrochloride (0.01 mol) were dissolved in absolute ethanol (15 ml), and then the mixture was refluxed for 6 h in an oil bath and monitored by TLC (ethyl acetate:hexane 7:3 v/v as eluent; a UV lamp was used to visualize the plates). After the completion of the reaction, as per TLC, the contents of the reaction mixture were poured into ice-cold water (50 ml). The obtained precipitates were filtered, washed two times, dried for 2 h at room temperature, and then recrystallized with ethenol. The structures of these compounds were confirmed via Fourier transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (H NMR) spectroscopy, carbon-13 nuclear magnetic resonance (C NMR) spectroscopy, and mass spectrometry. Anti-inflammatory activity was evaluated using the carrageenan-induced rat paw edema method.

RESULTS

The results indicated that three compounds ( and ) demonstrated significant anti-inflammatory potential (% edema inhibition 75.68, 74.48, & 71.86 in 2 h and 76.71, 75.56, & 72.32 in 3 h) with modest effectiveness (0.83, 0.81 & 0.71), low toxicity, and minimal adverse effects. The molecular docking analyses further elucidated the interaction with the active site COX-2 enzyme (PDB ID: 4COX) using Autodock Vina. The compounds and -8.7, -8.5, and -8.4 indicate good binding affinity (kcal/mol) and H-bond interaction with residues such as Cys41, Ala151, and Arg120 for COX-2, which also carried out RMSD values of 2.174, 41.13, and 22.25, which are decisive for the reported anti-inflammatory activity of diverse compounds.

CONCLUSIONS

The findings indicate that isoxazole derivatives have modest antiinflammatory potential, with compounds ( and ) acting as lead molecules to be studied further for pain relief with fewer adverse effects.

摘要

背景

本研究旨在探究13种取代异恶唑衍生物(5a - 5m)的抗炎活性。异恶唑是药物化学中的关键药效基团,以其广泛的药理活性而闻名。本研究探索了13种取代异恶唑衍生物(5a - 5m)的合成及抗炎潜力,其中[具体化合物]为新化合物。

目的

主要目的是合成一些新型取代异恶唑衍生物,通过计算方法评估它们与环氧化酶(COX - 1/2)的相互作用,并在实验动物中评估其抗炎效果。

方法

将取代查耳酮(0.01 mol)(2a - 2m)、乙醇钠(0.01 mol)和盐酸羟胺(0.01 mol)溶解于无水乙醇(15 ml)中,然后将混合物在油浴中回流6小时,并通过薄层色谱法(TLC)监测(以乙酸乙酯:己烷7:3 v/v作为洗脱剂;用紫外灯观察薄板)。反应完成后,根据TLC结果,将反应混合物的内容物倒入冰冷的水(50 ml)中。所得沉淀物经过过滤、洗涤两次、在室温下干燥2小时,然后用乙醇重结晶。这些化合物的结构通过傅里叶变换红外光谱(FT - IR)、质子核磁共振(H NMR)光谱、碳 - 13核磁共振(C NMR)光谱和质谱进行确认。使用角叉菜胶诱导的大鼠足爪肿胀法评估抗炎活性。

结果

结果表明,三种化合物([具体化合物])具有显著的抗炎潜力(2小时内水肿抑制率分别为75.68%、74.48%和71.86%,3小时内分别为76.71%、75.56%和72.32%),有效性适中(0.83、0.81和0.71),毒性低,不良反应最小。分子对接分析使用Autodock Vina进一步阐明了与活性位点COX - 2酶(PDB ID: 4COX)的相互作用。化合物[具体化合物]的结合亲和力良好(- 8.7、- 8.5和- 8.4 kcal/mol),与COX - 2的Cys41、Ala151和Arg120等残基存在氢键相互作用,其RMSD值分别为2.174、41.13和22.25,这些值对于多种化合物报道的抗炎活性具有决定性意义。

结论

研究结果表明异恶唑衍生物具有适度的抗炎潜力,化合物([具体化合物])作为先导分子有待进一步研究以减轻疼痛且不良反应较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/56b7567f3ee0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/371d76403ba9/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/143bf3d597f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/b4ded0d1851b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/0c79c58295f9/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/fed8ab5989b5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/56b7567f3ee0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/371d76403ba9/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/143bf3d597f2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/b4ded0d1851b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/0c79c58295f9/sc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/fed8ab5989b5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfe1/11617876/56b7567f3ee0/gr4.jpg

相似文献

1
Synthesis, characterization, molecular docking and pharmacological evaluation of isoxazole derivatives as potent anti-inflammatory agents.异恶唑衍生物作为强效抗炎剂的合成、表征、分子对接及药理评价
Heliyon. 2024 Nov 15;10(22):e40300. doi: 10.1016/j.heliyon.2024.e40300. eCollection 2024 Nov 30.
2
Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.发现具有潜在镇痛和抗炎活性的新型 2-(3-(萘-2-基)-4,5-二氢-1H-吡唑-1-基)噻唑衍生物:体外、体内和计算研究。
Bioorg Chem. 2024 Jun;147:107372. doi: 10.1016/j.bioorg.2024.107372. Epub 2024 Apr 17.
3
based Designing of benzothiazol-2-amine Derivatives as Analgesic and Anti-inflammatory Agents.基于苯并噻唑-2-胺衍生物的设计,作为镇痛和抗炎药物。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(4):230-260. doi: 10.2174/0118715230296273240725065839.
4
Design, synthesis, and biological evaluation of novel imidazole derivatives as analgesic and anti-inflammatory agents: experimental and molecular docking insights.新型咪唑衍生物的设计、合成及镇痛抗炎活性评价:实验与分子对接研究。
Sci Rep. 2024 Oct 4;14(1):23121. doi: 10.1038/s41598-024-72399-8.
5
Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes.发现小分子通过同时阻断关键 COX-2、5-LOX 和 PIM-1 激酶酶,成为结直肠癌的多靶点抑制剂。
Bioorg Chem. 2021 Oct;115:105171. doi: 10.1016/j.bioorg.2021.105171. Epub 2021 Jul 16.
6
Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.2-萘基反式二苯乙烯和氰基二苯乙烯作为抗癌剂的合成与评价
Anticancer Agents Med Chem. 2018;18(4):556-564. doi: 10.2174/1871521409666170412115703.
7
Synthesis, inhibition of cyclooxygenases and studies of new isoxazole derivatives.新型异恶唑衍生物的合成、环氧化酶抑制作用及研究
Front Chem. 2023 Sep 6;11:1222047. doi: 10.3389/fchem.2023.1222047. eCollection 2023.
8
Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.芳基/杂芳基取代的塞来昔布衍生物作为COX-2抑制剂:合成、抗炎活性及分子对接研究
Med Chem. 2017;13(5):484-497. doi: 10.2174/1573406413666170221093740.
9
Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE, TNF-α, IL-6 and histopathological study.新型基于四唑的选择性 COX-2 抑制剂:设计、合成、抗炎活性、PGE、TNF-α、IL-6 评价及组织病理学研究。
Bioorg Chem. 2020 Nov;104:104308. doi: 10.1016/j.bioorg.2020.104308. Epub 2020 Sep 24.
10
Synthesis, Biological Evaluation and QSAR Studies of Newer Isoxazole Derivatives.新型异恶唑衍生物的合成、生物学评价及定量构效关系研究
Antiinflamm Antiallergy Agents Med Chem. 2015;14(2):128-37. doi: 10.2174/1871523014666150812162343.

本文引用的文献

1
Insights into bacterial interactions: Comparing fluorine-containing 1,2,4-triazoles to antibiotics using molecular docking and molecular dynamics approaches.对细菌相互作用的见解:使用分子对接和分子动力学方法将含氟1,2,4-三唑与抗生素进行比较。
Heliyon. 2024 Sep 6;10(17):e37538. doi: 10.1016/j.heliyon.2024.e37538. eCollection 2024 Sep 15.
2
Design, synthesis, biological and computational screening of novel pyridine-based thiadiazole derivatives as prospective anti-inflammatory agents.新型吡啶基噻二唑衍生物作为潜在抗炎剂的设计、合成、生物学及计算机筛选
Heliyon. 2024 Apr 9;10(8):e29390. doi: 10.1016/j.heliyon.2024.e29390. eCollection 2024 Apr 30.
3
Dataset of acute oral toxicity and subacute neurotoxicity risk assessments of flavonoid-enriched fraction extracted from on Sprague Dawley rats.
从斯普拉格-道利大鼠中提取的富含黄酮类成分的急性经口毒性和亚急性神经毒性风险评估数据集。
Data Brief. 2023 Jul 15;49:109411. doi: 10.1016/j.dib.2023.109411. eCollection 2023 Aug.
4
Magnetic poly(1,8-diaminonaphthalene)-nickel nanocatalyst for the synthesis of antioxidant and antibacterial isoxazole-5(4)-ones derivatives.用于合成抗氧化和抗菌异恶唑-5(4)-酮衍生物的磁性聚(1,8-二氨基萘)-镍纳米催化剂
Heliyon. 2023 May 4;9(5):e15886. doi: 10.1016/j.heliyon.2023.e15886. eCollection 2023 May.
5
Synthesis, antimycobacterial screening, molecular docking, ADMET prediction and pharmacological evaluation on novel pyran-4-one bearing hydrazone, triazole and isoxazole moieties: Potential inhibitors of SARS CoV-2.新型含吡喃-4-酮腙、三唑和异恶唑部分的化合物的合成、抗分枝杆菌筛选、分子对接、ADMET预测及药理学评价:SARS-CoV-2的潜在抑制剂
J Mol Struct. 2023 Aug 5;1285:135461. doi: 10.1016/j.molstruc.2023.135461. Epub 2023 Mar 30.
6
Evaluation of acute and sub-chronic toxicity of bitter melon seed extract in Wistar rats.苦瓜籽提取物对Wistar大鼠的急性和亚慢性毒性评估。
Toxicol Rep. 2022 Apr 29;9:1024-1034. doi: 10.1016/j.toxrep.2022.04.024. eCollection 2022.
7
Design, Synthesis, and Evaluation of Novel Benzo[]isoxazole Derivatives as Anticonvulsants by Selectively Blocking the Voltage-Gated Sodium Channel Na1.1.新型苯并异恶唑衍生物的设计、合成及作为电压门控钠离子通道 Na1.1 选择性阻断剂的抗惊厥活性评价。
ACS Chem Neurosci. 2022 Mar 16;13(6):834-845. doi: 10.1021/acschemneuro.1c00846. Epub 2022 Feb 25.
8
Synthesis, spectral characterization, lethal dose (LD) and acute toxicity studies of 1,4-Bis(imidazolylazo)benzene (BIAB).1,4-双(咪唑基偶氮)苯(BIAB)的合成、光谱表征、致死剂量(LD)及急性毒性研究
Heliyon. 2021 Sep 9;7(9):e07969. doi: 10.1016/j.heliyon.2021.e07969. eCollection 2021 Sep.
9
Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.新型含茚酮螺环异恶唑啉衍生物的设计、合成及作为抗癌剂的选择性 COX-2 抑制作用的生物评价。
Bioorg Med Chem. 2021 Feb 15;32:115960. doi: 10.1016/j.bmc.2020.115960. Epub 2021 Jan 2.
10
Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.新型 N-苄基吡啶鎓部分与芳基异恶唑衍生物连接作为选择性丁酰胆碱酯酶抑制剂的研究:合成、生物评价和对接研究。
Bioorg Chem. 2019 Nov;92:103192. doi: 10.1016/j.bioorg.2019.103192. Epub 2019 Aug 10.